Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2000
08/10/2000WO2000045833A1 Hiv drug resistance system
08/10/2000WO2000045832A2 Regulation of anaesthesia
08/10/2000WO2000045831A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000WO2000045830A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/10/2000WO2000045825A1 Delivery system and methods for gene therapy
08/10/2000WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
08/10/2000WO2000045800A2 Immunosurpressive effects of pteridine derivatives
08/10/2000WO2000045792A1 Hydrogel particle formulations
08/10/2000WO2000045790A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
08/10/2000WO2000045771A2 Suppression of transformation of cells by the transcription factor egr
08/10/2000WO2000033861A3 Pharmaceutical compositions containing protein-disulfide isomerases
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000027424A3 Upregulation of endogenous prostaglandins to lower intraocular pressure
08/10/2000WO2000026368A3 Therapeutic antiangiogenic endostatin compositions
08/10/2000WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX
08/10/2000WO2000025827A3 Dna molecules encoding muc-1 and use thereof in tumor vaccination
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000024359A3 Use of gndf for treating retinal degeneration
08/10/2000WO2000023583A3 p53 BINDING AREAS
08/10/2000WO2000020604A3 Oxidoreductase molecules
08/10/2000WO2000014219A9 Peptide nucleic acid-oligoadenylate chimeric molecules
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000WO2000012707A9 14926 receptor, a novel g-protein coupled receptor
08/10/2000WO2000012118A8 Inhibiting cardiomyocyte death
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO2000010543A3 Medicament containing platinum complex compounds and the use thereof
08/10/2000WO2000009138A8 Nutritional compositions for preventing or treating hyperlipoproteinemia
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000WO1999006547A3 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
08/10/2000DE19905128A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid
08/10/2000DE19903876A1 Verfahren zur Induktion von prophylaktisch oder therapeutisch wirksamen Proteinen Method of inducing a prophylactic or therapeutically effective proteins
08/10/2000DE19903655A1 Hydrogel comprising protein or enzyme bonded to PEG via urea groups, useful as a dressing for wounds and burns
08/10/2000DE19903087A1 Behandlung von erektilen Dysfunktionen mit C-Typ Natriuretischem Polypeptid (CNP) als Monotherapie oder in Kombination mit Phosphodiesterasehemmern Treatment of erectile dysfunction with C-type natriuretic polypeptide (CNP) as monotherapy or in combination with phosphodiesterase inhibitors
08/10/2000DE19901594A1 Use of natural or recombinant tissue plasminogen activator for prevention and treatment of postoperative corneal healing disorders
08/10/2000CA2492661A1 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000CA2398197A1 Delivery system and methods for gene therapy
08/10/2000CA2371794A1 Human antibiotic proteins
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362231A1 Brain-derived alkali-soluble immunoregulatory composition
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2362049A1 Highly-mineralized osteogenic sponge compositions, and uses thereof
08/10/2000CA2362046A1 Osteogenic paste compositions and uses thereof
08/10/2000CA2361832A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use
08/10/2000CA2361658A1 T helper cell epitopes
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361612A1 Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
08/10/2000CA2361561A1 Immunosurpressive effects of pteridine derivatives
08/10/2000CA2361555A1 Hydrogel particle formulations
08/10/2000CA2361421A1 Therapeutic calcium phosphate particles and methods of manufacture and use
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2360800A1 Inhibition of the mhc class ii antigen presentation pathway and presentation to cd4+ cells
08/10/2000CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein
08/10/2000CA2360670A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000CA2360124A1 Regulation of anaesthesia
08/10/2000CA2321107A1 Materials for preventing arteriosclerosis, immunopotentiating materials, vertebrates fed with these materials and eggs thereof
08/09/2000WO2000052043A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
08/09/2000EP1026243A1 NUCLEIC ACID CAPABLE OF BINDING SPECIFICALLY TO Ras TARGET PROTEIN
08/09/2000EP1026240A2 Generation and selection of recombinant varied binding proteins
08/09/2000EP1026239A2 A new method for tapping the immunological repertoire
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025861A1 Pharmaceutical compositions of hydrophobically modified Hedgehog Proteins and their use
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025853A2 Pharmaceutical composition containing S-nitroso-heme proteins and use thereof
08/09/2000EP1025852A1 Hydrochlorides of vancomycin antibiotics and process for producing the same
08/09/2000EP1025851A1 Alpha-glucosidase inhibitor
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025840A2 Oral drug compositions and methods
08/09/2000EP1025242A1 A method of inhibiting an immune response to a recombinant vector
08/09/2000EP1025237A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025236A2 Human checkpoint kinase, hcds1, compositions and methods
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025229A1 Chemokines with amino-terminal modifications
08/09/2000EP1025228A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2
08/09/2000EP1025227A2 Human toll homologues
08/09/2000EP1025225A1 P-40/annexin i and related proteins and their role in multidrug resistance
08/09/2000EP1025224A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses
08/09/2000EP1025223A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
08/09/2000EP1025222A1 Genetic and protein therapy products for treating cystic fibrosis and inducing a glutathione-s-transferase function
08/09/2000EP1025221A2 ErbB-4 TARGETED RIBOZYMES
08/09/2000EP1025219A2 Antisense oligonucleotide sequences as inhibitors of microorganisms
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025212A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
08/09/2000EP1025127A1 Msh-receptor subtype selective cyclic peptides
08/09/2000EP1025126A1 Purification of molecules
08/09/2000EP1025125A1 Aggregates of human insulin derivatives
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025123A2 Method for the production of human blood cytokines
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR
08/09/2000EP1025119A1 Histogranin peptide and their analgesic use
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1024839A2 Reverse phase connective tissue repair composition
08/09/2000EP1024835A1 J-chain and analogues as epithelial cell targeting conjugates
1 ... 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 ... 3163